PRESS RELEASE published on 12/05/2023 at 16:00, 2 years 7 months ago First Light Diagnostics Receives FDA Clearance for its Rapid B. anthracis Toxin Test on the MultiPath Analyzer First Light Diagnostics receives FDA clearance for its SensiTox B. anthracis Toxin Test, a 20-minute, sensitive immunofluorescence assay for early detection of inhalation anthrax, marking a significant advancement in biodefense and public health FDA Clearance First Light Diagnostics SensiTox B. Anthracis Toxin Test Inhalation Anthrax Biodefense
Published on 07/11/2026 at 02:50, 1 day 5 hours ago Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 1 day 6 hours ago Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 1 day 6 hours ago Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 1 day 8 hours ago Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/11/2026 at 04:00, 1 day 4 hours ago CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027
Published on 07/10/2026 at 18:40, 1 day 13 hours ago AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives
Published on 07/10/2026 at 17:45, 1 day 14 hours ago WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026
Published on 07/10/2026 at 17:14, 1 day 15 hours ago Form 8.3 - SAFESTAY PLC: Opening Position Disclosure
Published on 07/10/2026 at 18:00, 1 day 14 hours ago Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 10:34, 1 day 21 hours ago Number of shares and voting rights - June 2026 (In French only)
Published on 07/09/2026 at 18:00, 2 days 14 hours ago Second-quarter 2026 activity: +7% (vs. Q2 2025)